Cargando…
The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells()
The transcription factor STAT3 is activated inappropriately in 70% of breast cancers, most commonly in triple negative breast cancer (TNBC). Although the transcriptional function of STAT3 is essential for tumorigenesis, the key target genes regulated by STAT3 in driving tumor pathogenesis have remai...
Autores principales: | Egusquiaguirre, Susana P., Yeh, Jennifer E., Walker, Sarah R., Liu, Suhu, Frank, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916089/ https://www.ncbi.nlm.nih.gov/pubmed/29621649 http://dx.doi.org/10.1016/j.neo.2018.03.004 |
Ejemplares similares
-
CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3
por: Egusquiaguirre, Susana P., et al.
Publicado: (2019) -
Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NF-κB protein in triple-negative breast cancer cells
por: Shi, Xiaoyu, et al.
Publicado: (2023) -
STAT3/NF-κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF-κB signaling pathway in a mouse model of atherosclerosis
por: An, Hyun-Jin, et al.
Publicado: (2023) -
The transcriptional modulator BCL6 as a molecular target for breast cancer therapy
por: Walker, Sarah R., et al.
Publicado: (2014) -
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
por: Esparza-López, José, et al.
Publicado: (2019)